Schedule 13D ownership disclosure

NOVELION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 67001K202

Event date: 2017-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,025,000
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-17-000468
Form type
SC 13D/A
Filer
NOVELION THERAPEUTICS INC.
CIK
CIK 827809
Filed
Jun 30, 2017
Reporting period
Jun 29, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub